[ad_1]
KUALA LUMPUR, February 21: The Pfizer-BioNtech vaccine, the first COVID-19 vaccine to receive conditional registration approval from the Drug Control Authority (DCA) and the National Pharmaceutical Regulatory Agency (NPRA) has gone through the proper evaluation process and its use will be closely monitored.
Tan Sri Chief Health Officer Dr. Noor Hisham Abdullah said that the vaccine produced by Pfizer-BioNTech, Comirnaty Concentrate for Dispersion For Injection, was approved on January 8 this year.
“Among the criteria examined by DCA and NPRA are the safety profile of the vaccine, its quality, safety and efficacy.
“The Ministry of Health is always committed to ensuring the safety and prioritizing the health of Malaysians by monitoring and examining all drugs, including purchased vaccines,” he said in a statement after the arrival of the first batch of vaccines to the Kuala Lumpur International Airport (KLIA) today.
He said conditional registration was granted to provide immediate access to the COVID-19 vaccine during the pandemic period using a ‘risk-based approach’, without compromising quality, safety and efficacy.
Dr Noor Hisham said that other criteria to allow conditional approval include that the regulatory body of the producing country or the reference regulatory body DCA or the World Health Organization (WHO) has registered the vaccine or received an authorization for use. of emergency.
Also present were the Minister of Health Datuk Seri Dr. Adham Baba, the Coordinating Minister of the National Immunization Program against Covid-19 Khairy Jamaluddin and the Minister of Transport Datuk Seri Dr. Wee Ka Siong.
The Airbus 330-300 carrying 312,390 doses of COVID-19 vaccine landed at 10:07 am today and was delivered to 16 vaccine storage centers across the country, namely six in Selangor, Johor (4), Kuala Lumpur ( 3), Penang (2) and one in Putrajaya.
Prime Minister Tan Sri Muhyiddin Yassin and Dr. Noor Hisham himself will be among the first to receive the Covid-19 vaccine on Wednesday, when the National Covid-19 Immunization Program is rolled out on Wednesday, ahead of schedule. – Called
[ad_2]
